ACCT 275 CH 8,9 - Rosmic Calvo ACCT 275 CH 8&9 HW CPA...

Info iconThis preview shows pages 1–3. Sign up to view the full content.

View Full Document Right Arrow Icon
Rosmic Calvo ACCT 275 CPA Questions 8-25 a) 3 b) 3 c) 4 d) 1 8-26 a) 3 b) 4 c) 4 8-27 a) 4 b) 1 c) 2 d) 4 9-22 a) 4 b) 4 c) 1 9-23 a) 1 b) 2 c) 3 9-24 a) 2 b) 4 c) 1 8-33 A. 2009 2008 2007 2006 Total Sales 14211 12916 11462 10351 Drug Sales 5126 5051 4821 4619 % 36.07 % 39.11% 42.06% 44.62%
Background image of page 1

Info iconThis preview has intentionally blurred sections. Sign up to view the full version.

View Full DocumentRight Arrow Icon
% Change - 3.04% -2.95% -2.56% Year Jones Gross  Profit % Change from  previous year Industry  Gross Profit  % Change  from  Previous  Year 2009 35.10% -0.90% 32.70% -0.20% 2008 36.00% -0.20% 32.90% -0.10% 2007 36.20% -0.30% 33.00% -0.20% 2006 36.50%   33.20%   Total Sales 14211 12916 11462 10351 Non-Drug Sales 9085 7865 6641 5732 % 63.93% 60.89% 57.94% 55.38% % Change 3.04% 2.95% 2.56% Both her explanations seem true. Although gross profit percent in the industry has been decreasing for the past three years, Jones Drugs gross profit percent has been declining at a much faster rate. Also, non-drug sales has been increasing, while drug sales have been steadily declining since 2006; this seems to support her assertion that competition from
Background image of page 2
Image of page 3
This is the end of the preview. Sign up to access the rest of the document.

Page1 / 4

ACCT 275 CH 8,9 - Rosmic Calvo ACCT 275 CH 8&9 HW CPA...

This preview shows document pages 1 - 3. Sign up to view the full document.

View Full Document Right Arrow Icon
Ask a homework question - tutors are online